Skip to content

Guided Placement of CRT-Leads

CT and 3D-Echocardiography Placement of CRT-Leads

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00764075
Acronym
EK138/08
Enrollment
132
Registered
2008-10-01
Start date
2008-10-31
Completion date
2011-06-30
Last updated
2011-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure; EF<35%; NYHA II, III or IV

Brief summary

In this open, prospective, randomized, parallel group, German-American, two-center, Phase I study the standard-approach CRT-implantation will be compared to a guided CRT-implantation after determining the site of latest contraction and placement of the electrode as close as possible to this site, using a 5-step-scheme of imaging methods determining the site of latest contraction prior to implantation.

Detailed description

Patients will be allocated to two groups with either 1. Guided implantation of the left ventricular lead 2. Empirical implantation of the left ventricular lead (current clinical standard) For Treatment Group a) the target vessel, which is the vessel with smallest distance between RLC and CVS is determined in advance and provided to the implanting physician. In case, this vessel is not amenable for lead positioning, a second vessel which is the second closest to the RLC is defined. For Treatment Group b), the physician has to choose the vessel where to place the electrode without knowing the exact spatial orientation between that particular side-branch and the RLC. In all patients, standard biventricular devices and leads are to be used. Aspects that are evaluated are: 1. Technical success in placing the electrode in the target vessel. 2. Failure due to dislocation during the implantation procedure or phrenic nerve stimulation. Also, procedure duration, radiation exposure, and complications occurring during the procedure as well as post- operatively will be documented.

Interventions

DEVICEBeutel TM

application of BeutelTM

OTHERstandard

standard procedure will be applied but no Beutel TM software

DEVICEsoftware Beutel TM

application of BeutelTM to patients data for determination of site of latest contraction

Sponsors

University of Chicago
CollaboratorOTHER
RWTH Aachen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Congestive heart failure, * Ejection fraction \<35%, * Complete left bundle branch block \>120ms, * NYHA II,III or IV

Exclusion criteria

* Patients not fulfilling the inclusion criteria or not capable/mental able to understand and follow the instructions; * Impaired kidney function (GFR \<30ml/min; * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Rate of non-responders regarding ejection fraction6 months

Secondary

MeasureTime frame
rate of non-responders regarding NYHA-classification, left end-diastolic and end-systolic volume6 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026